《港樓》何文田「傲玟」開放兩現樓示範單位 重推至今累銷140伙套現逾39億
曾由高銀金融前主席潘蘇通私人持有,後被接管的何文田「傲玟」今日(14日)開放兩個現樓示範單位,並推出限量「名校網專屬三重置業禮遇」。首十名成交買家可獲總值達28萬元優惠,包括20萬元家具現金券、以低至每月34元租用車位及首年租務管理費全免,搶攻暑期豪宅換樓檔期。
首輪優惠名額十名,發展商將視乎市場反應及銷情,考慮擴大優惠範圍至更多精選單位。
仲量聯行資深董事李遠峰稱,傲玟自2023年9月中重新推出市場發售,至今累積售出140伙,總成交金額超過39億元,而售出單位成交價介乎約1,566萬至逾1.1億元,呎價由17,700至32,632元不等,成交平均呎價約22,300元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.